Skip to main content
Clinical Trials/CTRI/2024/08/072422
CTRI/2024/08/072422
Not yet recruiting
Phase 4

Diagnostic performance of quantitative ultrasound parameters in assessing hepatic steatosis in NAFLD with MRI PDFF as the reference standard a prospective non randomized cohort study - NI

Samsung Medison Co.Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: E785- Hyperlipidemia, unspecified
Sponsor
Samsung Medison Co.Ltd
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Samsung Medison Co.Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who clinically suspected MASLD based on EASL–EASD–EASO Clinical Practice
  • Guidelines for the management of Metabolic Dysfunction\-Associated Steatotic Liver Disease
  • (MASLD), or patients who recommended to undergo either abdominal ultrasound
  • examination or liver MRI examination
  • 2\. Male or Female of Age \=18 years ,
  • 3\. Individuals who have decided to participate in the clinical study on their own will and have
  • provided the informed consent after reading/hearing and fully understanding the detailed explanations regarding the clinical study.

Exclusion Criteria

  • 1\. Subject who has disagreed the signing of informed consent form for this study
  • 2\. Subject who has a history of chronic liver disease due to etiology other than MASLD.
  • 3\. Subject who had a daily alcohol consumption ?30 g for men and ?20 g for women based on
  • EASL– ASD–EASO Clinical Practice Guidelines for the management of metabolic dysfunction associated steatotic liver disease (MASLD)
  • 4\. Subject who has a history of long\-term use of hepatotoxic drugs.
  • 5\. Subject with acute liver failure
  • 6\. Subject who has a history of esophageal varix, hydrops abdominis, hepatic coma, as well as
  • patents with signs of acute biliary obstruction, or those who had recent liver surgery.
  • 7\. Woman who is pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials